Hypoxic radioresistance: can ROS be the key to overcome it?
H Wang, H Jiang, M Van De Gucht, M De Ridder - Cancers, 2019 - mdpi.com
Radiotherapy is a mainstay treatment for many types of cancer and kills cancer cells via
generation of reactive oxygen species (ROS). Incorporating radiation with pharmacological …
generation of reactive oxygen species (ROS). Incorporating radiation with pharmacological …
The role of thioredoxin system in cancer: strategy for cancer therapy
JJ Jia, WS Geng, ZQ Wang, L Chen… - Cancer chemotherapy and …, 2019 - Springer
Purpose Cancer, a major public health problem, exhibits significant redox alteration.
Thioredoxin (Trx) system, including Trx and Trx reductase (TrxR), as well as Trx-interacting …
Thioredoxin (Trx) system, including Trx and Trx reductase (TrxR), as well as Trx-interacting …
Molecular pathways associated with oxidative stress and their potential applications in radiotherapy
Radiotherapy is an essential and effective treatment modality for cancer. Excessive levels of
reactive oxygen species (ROS) induced by ionizing radiation disrupt the redox homeostasis …
reactive oxygen species (ROS) induced by ionizing radiation disrupt the redox homeostasis …
Auranofin and cold atmospheric plasma synergize to trigger distinct cell death mechanisms and immunogenic responses in glioblastoma
Targeting the redox balance of malignant cells via the delivery of high oxidative stress
unlocks a potential therapeutic strategy against glioblastoma (GBM). We investigated a …
unlocks a potential therapeutic strategy against glioblastoma (GBM). We investigated a …
Hypoxic tumor microenvironment: Implications for cancer therapy
S Roy, S Kumaravel, A Sharma… - Experimental …, 2020 - journals.sagepub.com
Hypoxia or low oxygen concentration in tumor microenvironment has widespread effects
ranging from altered angiogenesis and lymphangiogenesis, tumor metabolism, growth, and …
ranging from altered angiogenesis and lymphangiogenesis, tumor metabolism, growth, and …
[HTML][HTML] Auranofin: Past to Present, and repurposing
M Yamashita - International Immunopharmacology, 2021 - Elsevier
Auranofin (AF), a gold compound, has been used to treat rheumatoid arthritis (RA) for more
than 40 years; however, its mechanism of action remains unknown. We revealed that AF …
than 40 years; however, its mechanism of action remains unknown. We revealed that AF …
Significance of the mitochondrial thioredoxin reductase in cancer cells: An update on role, targets and inhibitors
V Scalcon, A Bindoli, MP Rigobello - Free Radical Biology and Medicine, 2018 - Elsevier
Abstract Thioredoxin reductase 2 (TrxR2) is a key component of the mitochondrial
thioredoxin system able to transfer electrons to peroxiredoxin 3 (Prx3) in a reaction mediated …
thioredoxin system able to transfer electrons to peroxiredoxin 3 (Prx3) in a reaction mediated …
Oxidative stress-inducing anticancer therapies: taking a closer look at their immunomodulating effects
Cancer cells are characterized by higher levels of reactive oxygen species (ROS) compared
to normal cells as a result of an imbalance between oxidants and antioxidants. However …
to normal cells as a result of an imbalance between oxidants and antioxidants. However …
Multifunctional AuI‐based AIEgens: Manipulating Molecular Structures and Boosting Specific Cancer Cell Imaging and Theranostics
Gold (I) N‐heterocyclic carbene (AuI‐NHC) complexes have emerged as potential
anticancer agents owing to their high cytotoxicity and stability. Integration of their above …
anticancer agents owing to their high cytotoxicity and stability. Integration of their above …
Auranofin/vitamin C: a novel drug combination targeting triple-negative breast cancer
E Hatem, S Azzi, N El Banna, T He… - JNCI: Journal of the …, 2019 - academic.oup.com
Background Cancer cells from different origins exhibit various basal redox statuses and thus
respond differently to intrinsic or extrinsic oxidative stress. These intricate characteristics …
respond differently to intrinsic or extrinsic oxidative stress. These intricate characteristics …